Cardinal Health, Inc.
CAH · Drug Wholesalers · $52.4B
Cooling off
Not on a screen at the moment — no base, so no pivot to draw. The price and volume are below.
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The read
Cardinal Health, Inc. is not on any of the screens right now. Its relative strength rating is 67, and it sits in Drug Wholesalers.
Peers
Catalyst roadmap
Nothing dated in the next three months that we can ingest automatically.
Flagged by the market sweep
Several insiders soldInsider · 2026-09-18
7 insiders sold $59,552,442
Several insiders soldInsider · 2026-09-17
7 insiders sold $59,552,442
Several insiders soldInsider · 2026-09-16
7 insiders sold $59,552,442
Several insiders soldInsider · 2026-09-15
7 insiders sold $59,552,442
Several insiders soldInsider · 2026-09-12
7 insiders sold $59,552,442
Several insiders soldInsider · 2026-09-11
7 insiders sold $59,552,442
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool · 1 day agoIs Nuveen ESG Mid-Cap Value ETF (NUMV) a Strong ETF Right Now?Zacks Investment Research · 2 days agoBTSG Faces $200M IRA Hit but Efficiency May Protect ProfitabilityZacks Investment Research · 2 days agoCan CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?Zacks Investment Research · 3 days agoAbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool · 5 days agoAmgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool · 8 days ago
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray